Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna ’s COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 9, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA)...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Australia Health | Biotechnology | Clinical Trials | COVID-19 | Grants | Pharmaceuticals | Vaccines